Come up with a name for your new list and we'll add to it:
Anagin raised a round of funding on October 09, 2014. Investors include
National Institutes of Health.
Anagin is developing first-in-class novel targeted therapies for addressing pathologies associated with disrupted synaptic plasticity in the central nervous system leading to psychiatric diseases. Suc…